Has Michael Lyons received payments from drug or device companies?

Yes. Drug and device makers reported $1,348 in general payments to Michael Lyons across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Lyons did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Lyons come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Lyons

Pediatrics · Leominster, MANPI 1306834650

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $299, 6.9 times the $43 reported in 2019. Among pediatrics clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,348in general payments, 2019–2025

Across 75 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$215
GSK$160
Pfizer$86
Supernus Pharmaceuticals, Inc.$83
Merck$79
Collegium Pharmaceutical, Inc.$79
plus $645 from 18 others

What the payments were for

Food & beverage$1,33599%
Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	21	$215
GSK	7	$160
Pfizer	4	$86
Supernus Pharmaceuticals, Inc.	4	$83
Merck	5	$79
Collegium Pharmaceutical, Inc.	4	$79
Kaleo, Inc.	3	$67
Ironshore Pharmaceuticals Inc.	2	$63
Hologic Sales And Service, LLC	3	$60
Seqirus USA Inc	3	$59
Sanofi-aventis U.S. LLC	2	$49
Sanofi Pasteur Inc.	2	$47
ARS Pharmaceuticals Operations, Inc.	2	$45
Exeltis, USA Inc.	2	$43
Vertical Pharmaceuticals, LLC	2	$38
Biomarin Pharmaceutical Inc.	1	$25
Mayne Pharma Commercial LLC	1	$24
Rhythm Pharmaceuticals, Inc.	1	$24
Novo Nordisk	1	$20
AstraZeneca	1	$20
Verrica Pharmaceuticals Inc.	1	$19
Dermira, Inc.	1	$15
Avion Pharmaceuticals	1	$15
Tris Pharma Inc	1	$13

How this compares

$1,348 in reported general payments places this provider in the 90th percentile of 1,444 pediatrics providers in Massachusetts.

See all pediatrics providers in Massachusetts →

Other pediatrics in Leominster

R EzekowitzBoston$1.4M
Brian HamiltonCambridge$328K
Harald JueppnerBoston$158K
Courtney HannaBoston$150K
Michele BorisukBoston$117K
Chadi ElsaleebyBoston$108K
Aileen LorangerAcushnet$52K
Melissa Blackburn KierklaMonson$30K
Peter RappoWest Bridgewater$17K
Ian HardingWorcester$16K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →